The COVID-19 pandemic has been harsh to Intuitive Surgical dropping its stock price nearly 20 percent, however The Motley Fool thinks this is the perfect opportunity to buy into the company.
What you should know:
1. Because Intuitive's DaVinci device is heavily-used in elective procedures, the devicemaker's stock has taken a beating.
2. However, an aging population will mean the devices will still remain relevant once the COVID-19 pandemic subsidies.
3. Intuitive has room to weather an extended period of lost revenue because of proactive financial management, and once operations return to normal after initial demand for elective surgery subsidies, facilities are expected to resume purchasing surgical robots.